Exponent Q2 revenue flat at $132.9 million; net income falls to $26.6 million
Exponent reported second quarter 2025 revenues before reimbursements of $132.9 million, approximately flat year over year, and total revenues up 1% to $142.0 million. Net income fell to $26.6 million, or $0.52 per diluted share, from $29.2 million, or $0.57, a year earlier, and the company kept its full-year 2025 guidance while declaring a $0.30 quarterly dividend.
Key points
- Revenues before reimbursements were $132.9 million, approximately flat versus $132.4 million in Q2 2024; total revenues rose 1% to $142.0 million.
- Net income was $26.6 million, or $0.52 per diluted share, versus $29.2 million, or $0.57 per diluted share, in Q2 2024.
- Full-year 2025 guidance was maintained: revenues before reimbursements expected to grow in the low single digits, and EBITDA expected at 26.50% to 27.0% of revenues before reimbursements.
- Board declared a quarterly cash dividend of $0.30 per share, payable September 19, 2025, to stockholders of record as of September 5, 2025.
The filing
Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 31, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.